David Shaw’s Verona Pharma VRNA Stock Holding History

David Shaw’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-337,143	Closed	-$36M	–	5045
2025 Q3	$36M	Sell	337,143 -1,078,076	-76%	-$113M	0.02%	824
2025 Q2	$134M	Buy	1,415,219 +801,222	+130%	+$59.3M	0.09%	257
2025 Q1	$39M	Buy	+613,997	New	+$36.7M	0.03%	586
2023 Q2	–	Sell	-14,364	Closed	-$288K	–	4584
2023 Q1	$288K	Sell	14,364 -117,104	-89%	-$2.53M	﹤0.01%	3767
2022 Q4	$3.44M	Buy	+131,468	New	+$1.75M	﹤0.01%	2449

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

David Shaw's VRNA Position: Q4 2025 in Review

David Shaw sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 337,143 shares — an estimated $36M sold.

David Shaw first reported a position in VRNA in Q4 2022 and held it in 5 quarters. The position peaked at $134M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

David Shaw reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
David Shaw sold 337,143 Verona Pharma shares in Q4 2025, an estimated $36M.
David Shaw first reported a position in Verona Pharma in Q4 2022 and held it in 5 quarters.
David Shaw's Verona Pharma position peaked at $134M in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on D.E. Shaw & Co's 13F filing for Q4 2025, filed 17 Feb 2026.